Sponsor study identifier
observational
81
1 country
1
Study Start
March 11, 2021
Actual (reported)Primary Completion
March 22, 2021
Actual (reported)Study Completion
March 25, 2021
Actual (reported)The concept of enhanced recovery after surgery (ERAS) is utilizing in multiple specialties widely. Early tracheal extubation is one of the components of ERAS that enhances postoperative recovery and reduces the length of stay in intensive care unit (ICU).Dexmedetomidine is a highly selective, shorter-acting α2-adrenergic receptor agonist that has both analgesic and sedativeeffects.It was associated with decreased mortality, time to extubation, and hospital length of stay in cardiac surgical patients according to previous studies.The purpose of this study was to investigate the effect of perioperative dexmedetomidine on patients undergoing minimally invasive cardiac surgery(MICS) who were early extubated after surgery.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 25, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 11, 2021
Actual (reported)March 22, 2021
Actual (reported)March 25, 2021
Actual (reported)August 26, 2021
Actual (reported)September 8, 2021
Actual (reported)postoperative mechanical ventilation duration
from the time the patient arrived at the ICU until extubation
up to 1 week
ICU and hospital length of stay
through admission, up to 1 month
postoperative complications
according to ICD 10 on medical record, daily to discharge, up to 1 month
Dexmedetomidine infusion during the perioperative period
Did not have dexmedetomidine infusion during the perioperative period
perioperative dexmedetomidine infusion
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients were eligible for inclusion if they had undergone minimal invasive off-pump coronary artery bypass graft (CABG), valvular surgery or combined procedures at Far Eastern Memorial Hospital, New Taipei City, Taiwan between January 1, 2020 and August 31, 2020. Additionally patients were included if they were aged 20 years or older and were excluded if it was emergency surgery, if they had postoperative mechanical ventilation more than 6 hours or if they were extubated in the operating room.
Far Eastern Memorial Hospital
New Taipei City, 22061, Taiwan
Tsung-Hua Yang, MD
Far Eastern Memorial Hospital
81 participants (actual enrollment reported by the registry).
First Submitted
August 26, 2021
First Posted
September 8, 2021
Study Start
March 11, 2021
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
March 22, 2021
Actual (reported)Study Completion
March 25, 2021
Actual (reported)Last Updated
September 8, 2021
Record last verified: 2021-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: